Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

Insights are not available.
Coherent Market Insights
Head and Neck Cancer Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Cancer is the uncontrolled and abnormal growth of cells that results in formation of a mass called tumor. This tumor can be cancerous or benign. Head and neck cancer is the terminology used to define a number of different malignant tumors that develop in or around the

Coherent Market Insights
Plasma Fractionation Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Plasma fractionation is a process of separating various components of plasma, which in turn is a component of blood obtained through blood fractionation. Plasma is separated and can be used for many different medical applications. Plasma is taken from donors when whol

Coherent Market Insights
Bleeding Disorders Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

A bleeding disorder is a state in which the normal clotting function of blood is adversely affected. On an injury to the body, blood normally starts to clot to prevent major loss of blood. Occasionally, certain situations prevent blood from clotting properly, which ca

Coherent Market Insights
General Anesthesia Drugs Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

General anesthesia is a therapeutically induced condition of unconsciousness; that is, loss of protective reflexes, which results from the use of one or multiple general anesthetic agents. The drug is administered to allow performing the medical procedures which are u

Coherent Market Insights
Animal Antimicrobials and Antibiotics Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Antibiotics are used for a variety of purposes in the husbandry of livestock, including therapeutic (treatment when ill), curing a batch of animals when a minimum of one among the group is diagnosed ill (metaphylaxis, it is similar to the method bacterial meningitis i

Coherent Market Insights
Dilated Cardiomyopathy Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 – 2025

To Be Published : May 2018

Dilated cardiomyopathy (DCM) is a condition in which the heart gets enlarged and is not able to efficiently pump blood. The reduced heart function can affect the functioning of other organs such as lungs, liver, and kidney. The heart muscles begin to dilate (stretches

Coherent Market Insights
Orphan Drugs Market — Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

The drugs which are developed for treatment of rare diseases and conditions are referred to as orphan drugs. The rare diseases such as Tourette syndrome, Huntington’s disease, muscular dystrophy, myoclonus, and ALS (Lou Gehrig’s disease) are some of those

Coherent Market Insights
Parkinson's Disease Therapeutics Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Parkinson's disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson's disease progression leads to uncontrolled body movement of the pat

Coherent Market Insights
Smart Pills Market - Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Smart pills can be used to monitor the drug adherence, temperature and some other parameters in the patients. Smart pills are ingestible medical devices that can be taken orally to examine the gastrointestinal tract (GI).The advanced technology of smart pills helps in

Coherent Market Insights
Epidermal Growth Factors (EGF) Market - Global Industry Insights, Trends, Size, Share, Outlook and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Epidermal growth factors (EGF) is a protein that helps in stimulation of cell growth, cell proliferation and cell differentiation by binding to its respective receptors known as epidermal growth factor receptors. These receptors are found in several human tissues such

Coherent Market Insights
Zika Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Zika vaccines are developed for immunization & prevention against diseases caused by Zika virus. This virus belongs to genus Flavivirus and is transmitted by Aedes mosquitoes. The virus can also be transmitted through blood transfusion, sexual contact or from infe

Coherent Market Insights
Pediatric Clinical Trials Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

The clinical trials conducted on children’s for the research and development of drugs or formation of new drugs are called as pediatric clinical trials. Most of clinical trials are conducted on adults and in very rare clinical trials children’s are include

Coherent Market Insights
Angiosarcomas Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Angiosarcoma is a rare cancer of the inner lining of blood vessels, which occur in any area of the body, including the skin, breast, liver, spleen, and deep tissue and originates due to the transformation of mesenchymal cells. Angiosarcoma is known to appear on skin o

Coherent Market Insights
Nanomedicines Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Medical application of nanotechnology is referred as nanomedicine. Potential applications include in biological devices, nanomaterials, nanoelectronic biosensors, molecular nanotechnology including biological machines. Some of the recent problems for nanomedicines inc

Coherent Market Insights
Opioid Induced Side Effects Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Opioids are the class of drug that include strong pain relievers and illegal drugs such as heroin and illicit pain relievers for example hydrocodone, oxycodone, morphine and fentanyl. Also they are available legally on prescription. These drugs interact with opioid re

Coherent Market Insights
Ioversol Market - Global Industry Insights, Size, Share, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Ioversol is a white to off-white crystalline powder having a crystalline sulfide-like odor. It is a non-ionic radiological contrast agent that is included in a group of drugs known as radiopaque contrast agents. It contains iodine, a substance that has the ability to

Coherent Market Insights
Polio Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Poliomyelitis is highly infectious disease caused by poliovirus. It is also known as polio or infantile paralysis. The virus belongs to genus Enterovirus which is a type of single-stranded RNA virus. There are three serotypes of poliovirus: P1,

Coherent Market Insights
Breast Cancer Therapeutics Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2016–2024

To Be Published : May 2018

Cancer is essentially the uncontrolled growth of certain cells in the body that crowd out normal cells over time. When cells in the breast begin to grow out of control it may lead to breast cancer. These cells generally form a tumor that can felt as a lump, which can

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.